Multiple Myeloma — Trials

Multiple Myeloma — Trials · CancerIndex

Clinical trials

Registered studies

3,384 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 814
Recruiting: 414
Ph III recruiting: 54
Growth YoY: +13.3%
Industry share: 29%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.1%
Trials / 1,000 deaths: 70.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (537)

clinicaltrialsPublishedShowing 51–53 of 53 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00104104	A Multiple Myeloma Trial in Patients With Bone Metastases	completed	Phase 4	179	Novartis PharmaceuticalsINDUSTRY	1	Jun 29, 2011	clinicaltrials
NCT01249690	Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma	unknown	Phase 4	100	Second Military Medical UniversityOTHER	1	Nov 30, 2010	clinicaltrials
NCT00257114